Elfriede Dall

1.2k total citations
26 papers, 929 citations indexed

About

Elfriede Dall is a scholar working on Molecular Biology, Biotechnology and Oncology. According to data from OpenAlex, Elfriede Dall has authored 26 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Biotechnology and 5 papers in Oncology. Recurrent topics in Elfriede Dall's work include Biochemical and Structural Characterization (14 papers), Enzyme Production and Characterization (6 papers) and Antimicrobial Peptides and Activities (5 papers). Elfriede Dall is often cited by papers focused on Biochemical and Structural Characterization (14 papers), Enzyme Production and Characterization (6 papers) and Antimicrobial Peptides and Activities (5 papers). Elfriede Dall collaborates with scholars based in Austria, Germany and Denmark. Elfriede Dall's co-authors include Hans Brandstetter, Chiara Cabrele, Peter Briza, Brigitta Elsässer, Wai Tuck Soh, Mario Schubert, Sven O. Dahms, Keqiang Ye, Christof Regl and Seong Su Kang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Elfriede Dall

22 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elfriede Dall Austria 15 566 259 150 135 122 26 929
Bernd Gerhartz Switzerland 18 773 1.4× 435 1.7× 204 1.4× 76 0.6× 119 1.0× 29 1.2k
Jon I. Williams United States 19 645 1.1× 122 0.5× 131 0.9× 66 0.5× 52 0.4× 46 1.1k
Monica Marra Italy 17 644 1.1× 202 0.8× 167 1.1× 31 0.2× 80 0.7× 25 1.1k
Schammim Ray Amith Canada 19 734 1.3× 138 0.5× 171 1.1× 35 0.3× 84 0.7× 20 1.1k
Matthew J. McKay Australia 23 606 1.1× 110 0.4× 83 0.6× 51 0.4× 56 0.5× 55 1.2k
Maciej Stawikowski United States 14 446 0.8× 107 0.4× 90 0.6× 43 0.3× 48 0.4× 31 663
Corina Borghouts Germany 20 875 1.5× 265 1.0× 82 0.5× 19 0.1× 91 0.7× 29 1.2k
A.L.B. Ambrosio Brazil 19 944 1.7× 68 0.3× 349 2.3× 70 0.5× 54 0.4× 32 1.4k
Masaharu Tamai Japan 13 595 1.1× 186 0.7× 219 1.5× 71 0.5× 87 0.7× 20 993
Claudia R. Oliva United States 27 1.2k 2.1× 288 1.1× 542 3.6× 143 1.1× 75 0.6× 44 2.0k

Countries citing papers authored by Elfriede Dall

Since Specialization
Citations

This map shows the geographic impact of Elfriede Dall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elfriede Dall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elfriede Dall more than expected).

Fields of papers citing papers by Elfriede Dall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elfriede Dall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elfriede Dall. The network helps show where Elfriede Dall may publish in the future.

Co-authorship network of co-authors of Elfriede Dall

This figure shows the co-authorship network connecting the top 25 collaborators of Elfriede Dall. A scholar is included among the top collaborators of Elfriede Dall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elfriede Dall. Elfriede Dall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dall, Elfriede, Sebastian Rasch, Simon Husby, et al.. (2025). Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study. PubMed. 2(3). 100128–100128.
2.
Soh, Wai Tuck, Fatih Demir, Raimund Tenhaken, et al.. (2023). Phytocystatin 6 is a context‐dependent, tight‐binding inhibitor of Arabidopsis thaliana legumain isoform β. The Plant Journal. 116(6). 1681–1695. 2 indexed citations
3.
Brandstetter, Hans, et al.. (2023). Arabidopsis thaliana Phytocystatin 6 Forms Functional Oligomer and Amyloid Fibril States. Biochemistry. 62(23). 3420–3429. 1 indexed citations
4.
Blöchl, Constantin, et al.. (2023). Legumain Functions as a Transient TrkB Sheddase. International Journal of Molecular Sciences. 24(6). 5394–5394.
5.
Briza, Peter, et al.. (2022). Structural and functional studies of legumain–mycocypin complexes revealed a competitive, exosite-regulated mode of interaction. Journal of Biological Chemistry. 298(10). 102502–102502.
6.
Dall, Elfriede, et al.. (2022). Production of Functional Plant Legumain Proteases Using the Leishmania tarentolae Expression System. Methods in molecular biology. 2447. 35–51. 3 indexed citations
7.
8.
Dall, Elfriede, Wai Tuck Soh, Fatih Demir, et al.. (2020). Structural and functional studies of Arabidopsis thaliana legumain beta reveal isoform specific mechanisms of activation and substrate recognition. Journal of Biological Chemistry. 295(37). 13047–13064. 21 indexed citations
9.
Silva, Elany Barbosa da, Elfriede Dall, Peter Briza, Hans Brandstetter, & Rafaela Salgado Ferreira. (2019). Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design. Acta Crystallographica Section F Structural Biology Communications. 75(6). 419–427. 16 indexed citations
10.
Dall, Elfriede, et al.. (2018). Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states. Journal of Biological Chemistry. 293(34). 13151–13165. 23 indexed citations
11.
Elsässer, Brigitta, et al.. (2018). Structural analyses of Arabidopsis thaliana legumain γ reveal differential recognition and processing of proteolysis and ligation substrates. Journal of Biological Chemistry. 293(23). 8934–8946. 34 indexed citations
12.
Dall, Elfriede, et al.. (2018). Crystal Structure of Plant Legumain Reveals a Unique Two-Chain State with pH-Dependent Activity Regulation. The Plant Cell. 30(3). 686–699. 54 indexed citations
13.
14.
Zhang, Zhentao, Obiamaka Obianyo, Elfriede Dall, et al.. (2017). Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease. Nature Communications. 8(1). 14740–14740. 115 indexed citations
15.
Soh, Wai Tuck, Peter Briza, Elfriede Dall, et al.. (2017). Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S. International Journal of Molecular Sciences. 18(10). 2156–2156. 9 indexed citations
16.
Dall, Elfriede, et al.. (2015). Struktur und Mechanismus einer Aspartimid‐abhängigen Peptidligase in humanem Legumain. Angewandte Chemie. 127(10). 2959–2964. 1 indexed citations
17.
Dall, Elfriede, et al.. (2015). Structure and Mechanism of an Aspartimide‐Dependent Peptide Ligase in Human Legumain. Angewandte Chemie International Edition. 54(10). 2917–2921. 69 indexed citations
18.
Dall, Elfriede & Hans Brandstetter. (2015). Structure and function of legumain in health and disease. Biochimie. 122. 126–150. 213 indexed citations
19.
Dall, Elfriede, et al.. (2015). Protease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity. Scientific Reports. 5(1). 12707–12707. 36 indexed citations
20.
Dall, Elfriede & Hans Brandstetter. (2011). Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 68(1). 24–31. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd Gerhartz Breakdown of academic impact, for papers by Jon I. Williams Breakdown of academic impact, for papers by Monica Marra Breakdown of academic impact, for papers by Schammim Ray Amith Breakdown of academic impact, for papers by Matthew J. McKay Breakdown of academic impact, for papers by Maciej Stawikowski Breakdown of academic impact, for papers by Corina Borghouts Breakdown of academic impact, for papers by A.L.B. Ambrosio Breakdown of academic impact, for papers by Masaharu Tamai Breakdown of academic impact, for papers by Claudia R. Oliva
Rankless by CCL
2026